Previous Article | Next Article ![]()
Journal of Clinical Microbiology, November 1998, p. 3309-3316, Vol. 36, No. 11
Corporación para Investigaciones
Biológicas,1 and
Laboratorio
Central de Investigaciones, Facultad de Medicina, Universidad de
Antioquia,3 Medellín, Colombia, and
St. John's Institute of Dermatology, Guy's Hospital,
London, England2
Received 9 June 1998/Returned for modification 1 August
1998/Accepted 19 August 1998
Serological diagnosis and follow-up of paracoccidioidomycosis (PCM)
patients have relied mainly on the detection of antibody responses by
using techniques such as complement fixation (CF) and immunodiffusion.
We recently described a novel inhibition enzyme-linked immunosorbent
assay (inh-ELISA) which proved to be useful in the diagnosis of PCM via
the detection of an 87-kDa determinant in patient sera (B. L. Gomez, J. I. Figueroa, A. J. Hamilton, B. Ortiz, M. A. Robledo, R. J. Hay, and A. Restrepo, J. Clin. Microbiol.
35:3278-3283, 1997). This test has now been assessed as a means of
following up PCM patients. A total of 24 PCM patients, classified
according to their clinical presentation (6 with the acute form of the
disease, of whom two had AIDS, 12 with the multifocal form of the
disease, and 6 with the unifocal form of the disease), were studied.
The four human immunodeficiency virus-negative patients with acute PCM
showed a statistically significant decrease in circulating antigen
levels after the start of antifungal therapy. Antigen levels in this
group became negative by our criteria (
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Antigenemia in Patients with
Paracoccidioidomycosis: Detection of the 87-Kilodalton
Determinant during and after Antifungal Therapy
2.3 µg/ml) before week 20 and remained so in three of four of these patients. In contrast, the
two AIDS patients who also presented with the acute form of PCM showed
no statistically significant decrease in circulating antigen levels
even after 68 weeks of therapy. Taken together as a group, the patients
with the multifocal form showed a statistically significant decrease in
antigenemia after 28 weeks of therapy. In addition, five of six
patients with the unifocal form became antigen negative by week 40. Antigen level decrease mirrored clinical cure in the majority of
patients in all clinical groups; in contrast, measurement of anti-PCM
antibodies via the CF test showed wide fluctuations in titers during
the follow-up period. The inh-ELISA for the detection of the 87-kDa
Paracoccidioides brasiliensis determinant would appear to
be a valuable additional tool in the follow-up of PCM patients.
*
Corresponding author. Mailing address: St John's
Institute of Dermatology, Dermatology Laboratory, 5th Floor, Thomas Guy
House, Guy's Hospital, London SE1 9RT, United Kingdom. Phone: 0171 955 4663 Fax: 0171 407 6689. E-mail:
g.beatriz{at}umds.ac.uk.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»